Barium sulfate
Sold as Polibar rapid, Axim e-z-hd, Axim e-z-paque, Axim e-z-cat, Axim polibar acb, Axim readicat, Entero vu, Baritop
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 3
- Registrations
- 8
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Macmed Pharma (Pty) LtdCancelled | Polibar rapid | Not stated | 280117 | S4 | None |
| Axim Pharmaceuticals (Pty) Ltd1 of 6 cancelled | Axim e-z-hd, Axim e-z-paque, Axim e-z-cat, Axim polibar acb, Axim readicat, Entero vu | 2 %, 100 g | 350124, 350125, 350126, 350129, 370521, A400210 | S4 | PIPIL |
| Sanofi-aventis South Africa (Pty) LtdCancelled | Baritop | 100 | C0213 | S4 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Polibar rapid EACH 100 ml SUSPENSION CONTAINS BARIUM SULFATE 100 g | Not listed | 28011728/28/0117 | Cancelled | S4 | None |
| Axim e-z-hd EACH 100,0 g POWDER CONTAINS: BARIUM SULFATE 98,0 g | Not listed | 35012435/28/0124 | Registered | S4 | None |
| Axim e-z-paque EACH 100,0 g POWDER CONTAINS BARIUM SULFATE 96,3045 g | Not listed | 35012535/28/0125 | Registered | S4 | None |
| Axim e-z-cat EACH 100,0 ml SUSPENSION CONTAINS: BARIUM SULFATE 4,8710 g | Not listed | 35012635/28/0126 | Registered | S4 | None |
| Axim polibar acb EACH 100,0 g POWDER CONTAINS: BARIUM SULFATE 96,0 g | 100 gPowder for rectal suspension | 35012935/28/0129Approved 2 February 2023 | Registered | S4 | PIPIL |
| Axim readicat 2 % EACH 100,0 ml SUSPENSION CONTAINS: BARIUM SULFATE 2,0898 g | 2 % | 37052137/28/0521 | Registered | S4 | None |
| Entero vu EACH 100,0 g POUCH CONTAINS BARIUM SULFATE 81,0 g | Not listed | A400210A40/28/0210 | Cancelled | S4 | None |
| Baritop 100 suspension EACH 100 ml CONTAINS BARIUM SULFATE 100,0 g | 100Suspension | C0213C/28/213 | Cancelled | S4 | None |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Barium sulfate
S4: Barium sulfate
Consolidated Schedules 06 July 2026, line 5435
Pharmacological class: Contrast media (class 28)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Axim polibar acb, Axim Pharmaceuticals (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.